MedTrace Logo

Blue Light in the Treatment of Inflammatory Skin Diseases

NCT06516783 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2024-07-24

No results posted yet for this study

Summary

The goal of this clinical trial is to assess the effectiveness of full-body blue light irradiations in the treatment of inflammatory skin diseases (atopic dermatitis, psoriasis, eczema) and chronic pruritus in adult and pediatric populations.

The main questions it aims to answer are:

* If blue light irradiations have an impact on the improvement in skin condition
* If blue light irradiations affect the patients' quality of life
* If blue light irradiations decrease pruritus

Participants will:

* Be administered phototherapeutic blue light (453 nm) for 15 minutes to each side of the body (30 minutes in total), 3-5 times per week. The study is scheduled for a maximum of 60 irradiations of blue light.
* Complete the Dermatology Life Quality Index questionnaire and a 10-item pruritus severity scale
* Be assessed using dermatologic scales
* Have blood samples collected

Conditions

Interventions

DEVICE

Full Body Blue GEN 1.0 device

Full body blue irradiation in the treatment of inflammatory skin diseases and chronic pruritus

Sponsors & Collaborators

  • Medical University of Lodz

    lead OTHER

Principal Investigators

  • Magdalena Sadowska · Medical University of Lodz

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-27
Primary Completion
2022-11-25
Completion
2022-11-25

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06516783 on ClinicalTrials.gov